Tag Archives: crizotinib

Planning Beyond the Petri Dish: A Pfizer Case Study

Pfizer’s crizotinib development program combined organization, art, and science— and a large dose of unforeseen risk. The path to commercializing a breakthrough discovery is rarely a linear process. The orderly rationale of the scientific method is often overtaken by the random artistry of passion, personality, business culture, and sheer luck. Each plays a significant role […]
Posted in Emerging Markets, Global, R&D | Also tagged , , , , , , | Leave a comment
  • Categories

  • Meta